Non-Invasive Respiratory Therapy Market Size is valued at USD 2.36 Bn in 2023 and is predicted to reach USD 3.61 Bn by the year 2031 at a 5.57% CAGR during the forecast period for 2024-2031.
Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma, sleep apnea, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (ARDS). Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. Continuous technological breakthroughs have resulted in the creation of more efficient, user-friendly, and portable non-invasive respiratory equipment.
Smart inhalers, wearable gadgets, and telemedicine solutions improve the patient experience and adherence to therapy. Factors such as rising respiratory illnesses and a surge in demand for non-invasive procedures are expected to drive market expansion in the coming years. Furthermore, benefits connected with various non-invasive (NIV) ventilators are other variables related to increased device acceptance and market expansion.
However, the emergence of the COVID-19 pandemic had a substantial impact on the market under consideration. Because of the pandemic's abrupt onset, the market saw a short-term negative impact due to decreased patient visits to hospitals and clinics. However, in the later stages of the pandemic, the market experienced tremendous growth due to increasing demand for NIV for COVID-19 patients and other chronic respiratory illness patients.
Competitive Landscape
Some Major Key Players In The Non-Invasive Respiratory Therapy Market:
- ResMed Inc.
- Teleflex Incorporated
- Hamilton Medical
- Koninklijke Philips N.V.
- Heyer Medical AG
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Airon Corporation
- Drägerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Limited
- Baxter International Inc.
- WILAmed GmbH
- Getinge AB
- Others
Market Segmentation:
The Non-Invasive Respiratory Therapy Market is segmented on the basis of product, application, and end-use. As per the product, the market is divided into Non-invasive Positive-pressure Ventilator (PPV) and non-invasive Negative Pressure Ventilator (NPV). The Positive-pressure Ventilator (PPV) segment includes Bi-level Positive Airway Pressure Ventilator (BiPAP), Constant Positive Airway Pressure Ventilator (CPAP), and Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP). According to the application, the market consists of Asthma & Chronic Obstructive Pulmonary Disease (COPD), respiratory distress syndrome, and Others. The end-user segment includes Hospitals, Ambulatory Surgical Centers (ASCs), and Others.
Based On The Positive-Pressure Ventilator (PPV), The Constant Positive Airway Pressure Ventilator (CPAP) Segment Is Accounted As A Major Contributor In The Non-Invasive Respiratory Therapy Market.
The Constant Positive Airway Pressure Ventilator (CPAP) category is expected to hold a major share in the global Non-Invasive Respiratory Therapy Market in 2024. This is due to the fact that Continuous Positive Airway Pressure (CPAP) is a type of positive airway pressure used to maintain a constant pressure during both inspiration and expiration. The use of CPAP preserves PEEP, reduces atelectasis, increases alveolar surface area, improves Ventilation/Perfusion (V/Q) matching, and hence improves oxygenation. While CPAP alone is frequently insufficient for sustaining ventilation, extra pressure support during inspiration in the form of Inspiratory Positive Airway Pressure (IPAP) or Bilevel Positive Airway Pressure (BiPAP) for non-invasive ventilation is required.
Asthma & Chronic Obstructive Pulmonary Disease (COPD) Segment Witnessed Growth At A Rapid Rate.
The Asthma & Chronic Obstructive Pulmonary Disease (COPD) segment is projected to rapid growth in the global Non-Invasive Respiratory Therapy Market. Asthma and COPD problems are becoming more common, which has contributed to the rise in their prevalence. According to the WHO, COPD is the world's third leading reason of death, accounting for 3.23 million fatalities. Low- and middle-income countries (LMIC) account for around 90% of COPD fatalities among people under the age of 70. Tobacco use is responsible for more than 70% of COPD cases in high-income nations and 30%-40% of COPD cases in low- and middle-income countries, with household air pollution being a major risk factor. Furthermore, new product launches by prominent companies are projected to boost revenue growth in this market.
In The Region, The North America Non-Invasive Respiratory Therapy Market Holds A Significant Revenue Share.
The North American non-invasive Respiratory Therapy Market is expected to record the maximum market revenue share in the near future, attributed to the increased frequency of respiratory illnesses. The market in the United States will account for the highest share in 2024, owing to technical improvements in non-invasive ventilators and the rising frequency of respiratory illnesses. According to the American Lung Association, approximately 34 million Americans are affected by chronic respiratory disorders, which include asthma and COPD, as well as emphysema and chronic bronchitis. Furthermore, new technical breakthroughs in mechanical ventilators will likely fuel this region's market revenue growth throughout the projection period. Moreover, Europe is expected to grow significantly within the forecast period. This is because of the rising incidence of respiratory illnesses and technological developments in non-invasive ventilators, as well as the country's rising prevalence of sleep apnea.
Recent Developments:
- In June 2021, Medline Industries, Inc. ("Medline") acquired a substantial portion of Teleflex Incorporated's Respiratory business for $286 million in cash, less $12 million in working capital not transferred to Medline. The divestiture was finalized by Teleflex Incorporated, a leading global provider of healthcare supplies and services.
- In Nov 2020, Philips released a brand-new non-invasive ventilator specially made for people with COPD. With the Philips Ventilator BiPAP A40 EFL, healthcare professionals could easily check for and find expiratory flow limitation (EFL) to get the best homecare therapy.
Non-Invasive Respiratory Therapy Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.36 Bn |
|
Revenue Forecast In 2031 |
USD 3.61 Bn |
|
Growth Rate CAGR |
CAGR of 5.57 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, Product, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
ResMed Inc., Teleflex Incorporated, Hamilton Medical, Koninklijke Philips N.V., Heyer Medical AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Airon Corporation, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Baxter International Inc., WILAmed GmbH, Getinge AB, and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
